Correlation Between Protalix Biotherapeutics and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and ATyr Pharma, you can compare the effects of market volatilities on Protalix Biotherapeutics and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and ATyr Pharma.
Diversification Opportunities for Protalix Biotherapeutics and ATyr Pharma
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Protalix and ATyr is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and ATyr Pharma go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and ATyr Pharma
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.65 times more return on investment than ATyr Pharma. However, Protalix Biotherapeutics is 1.53 times less risky than ATyr Pharma. It trades about 0.02 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.04 per unit of risk. If you would invest 160.00 in Protalix Biotherapeutics on September 3, 2024 and sell it today you would earn a total of 7.00 from holding Protalix Biotherapeutics or generate 4.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 74.74% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. ATyr Pharma
Performance |
| Timeline |
| Protalix Biotherapeutics |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protalix Biotherapeutics and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and ATyr Pharma
The main advantage of trading using opposite Protalix Biotherapeutics and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Protalix Biotherapeutics vs. DiaMedica Therapeutics | Protalix Biotherapeutics vs. Lyra Therapeutics | Protalix Biotherapeutics vs. Centessa Pharmaceuticals PLC |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |